133 related articles for article (PubMed ID: 9850649)
1. Glutathione S-transferase pi immunostaining of cisplatin-resistant ovarian cancer cells in ascites.
Kase H; Kodama S; Nagai E; Tanaka K
Acta Cytol; 1998; 42(6):1397-402. PubMed ID: 9850649
[TBL] [Abstract][Full Text] [Related]
2. [Value of P-glycoprotein and glutathione S-transferase-pi as chemo-resistant indicators in ovarian cancers].
Zhang F; Qi L; Chen H
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):313-6. PubMed ID: 11783115
[TBL] [Abstract][Full Text] [Related]
3. [The expression of glutathione S-transferase pi in human ovarian cancer as an indicator of resistance to chemotherapy].
Li L; Yao D; Chen X
Zhonghua Fu Chan Ke Za Zhi; 1998 Feb; 33(2):95-7. PubMed ID: 10682429
[TBL] [Abstract][Full Text] [Related]
4. Expression of glutathione S-transferase-pi in human ovarian cancer as an indicator of resistance to chemotherapy.
Hamada S; Kamada M; Furumoto H; Hirao T; Aono T
Gynecol Oncol; 1994 Mar; 52(3):313-9. PubMed ID: 8157188
[TBL] [Abstract][Full Text] [Related]
5. Glutathione S-transferase-pi expression and glutathione concentration in ovarian carcinoma before and after chemotherapy.
Cheng X; Kigawa J; Minagawa Y; Kanamori Y; Itamochi H; Okada M; Terakawa N
Cancer; 1997 Feb; 79(3):521-7. PubMed ID: 9028363
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
[TBL] [Abstract][Full Text] [Related]
7. [Expression of glutathione S-transferase-pi in operative specimens as marker of chemoresistance in patients with ovarian cancer].
Huang J; Gu M; Chen C
Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):458-61. PubMed ID: 9639737
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of glutathione S-transferase-Pi can predict chemotherapy response in patients with nonsmall cell lung carcinoma.
Bai F; Nakanishi Y; Kawasaki M; Takayama K; Yatsunami J; Pei XH; Tsuruta N; Wakamatsu K; Hara N
Cancer; 1996 Aug; 78(3):416-21. PubMed ID: 8697385
[TBL] [Abstract][Full Text] [Related]
9. Expression of glutathione S-transferase pi (GST-pi) in human malignant ovarian tumors.
Satoh T; Nishida M; Tsunoda H; Kubo T
Eur J Obstet Gynecol Reprod Biol; 2001 Jun; 96(2):202-8. PubMed ID: 11384808
[TBL] [Abstract][Full Text] [Related]
10. Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas.
van der Zee AG; Hollema H; Suurmeijer AJ; Krans M; Sluiter WJ; Willemse PH; Aalders JG; de Vries EG
J Clin Oncol; 1995 Jan; 13(1):70-8. PubMed ID: 7799045
[TBL] [Abstract][Full Text] [Related]
11. Glutathione-S transferase-pi expression in non small cell lung cancer in the assessment of response to chemotherapy.
Unsal M; Akpolat I; Kandemir B
Saudi Med J; 2003 May; 24(5):493-8. PubMed ID: 12847624
[TBL] [Abstract][Full Text] [Related]
12. Augmented expression of metallothionein and glutathione S-transferase pi as unfavourable prognostic factors in cisplatin-treated ovarian cancer patients.
Surowiak P; Materna V; Kaplenko I; Spaczyński M; Dietel M; Lage H; Zabel M
Virchows Arch; 2005 Sep; 447(3):626-33. PubMed ID: 15968547
[TBL] [Abstract][Full Text] [Related]
13. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors.
Cullen KJ; Newkirk KA; Schumaker LM; Aldosari N; Rone JD; Haddad BR
Cancer Res; 2003 Dec; 63(23):8097-102. PubMed ID: 14678959
[TBL] [Abstract][Full Text] [Related]
14. Glutathione concentration may be a useful predictor of response to second-line chemotherapy in patients with ovarian cancer.
Kigawa J; Minagawa Y; Kanamori Y; Itamochi H; Cheng X; Okada M; Oishi T; Terakawa N
Cancer; 1998 Feb; 82(4):697-702. PubMed ID: 9477102
[TBL] [Abstract][Full Text] [Related]
15. [Expression of glutathione S-transferase pi and numerical aberration of chromosome 11 in human ovarian cancer as a prognostic indicator].
Yokoyama Y; Fukushi Y; Kunugi T; Maruyama H; Sato S; Saito Y
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Feb; 48(2):118-24. PubMed ID: 8718547
[TBL] [Abstract][Full Text] [Related]
16. [An immunohistological study on expression of glutathione S-transferase pi (form) in human ovarian carcinoma].
Satoh T; Nishida M; Miyazaki Y; Sugita M; Arisawa Y; Oki A; Nishide K; Kono K; Tsunoda H; Kubo T
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Sep; 47(9):931-8. PubMed ID: 7594904
[TBL] [Abstract][Full Text] [Related]
17. Estimation of glutathione S-transferase and its Pi isoenzyme in tumor tissues and sera of patients with ovarian cancer.
Ghalia AA; Rabboh NA; el Shalakani A; Seada L; Khalifa A
Anticancer Res; 2000; 20(2B):1229-35. PubMed ID: 10810426
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of glutathione S-transferase mu expression in ovarian tumors.
Matsumoto T; Hayase R; Kodama J; Kamimura S; Yoshinouchi M; Kudo T
Eur J Obstet Gynecol Reprod Biol; 1997 Jun; 73(2):171-6. PubMed ID: 9228500
[TBL] [Abstract][Full Text] [Related]
19. [An immunohistological study on expression of glutathione S-transferase pi (form) in human endometrial carcinoma].
Satoh T; Nishida M; Oki A; Nishide K; Tsunoda H; Kubo T
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Feb; 48(2):133-8. PubMed ID: 8718549
[TBL] [Abstract][Full Text] [Related]
20. The clinical predictivity of biomarkers of stage III-IV epithelial ovarian cancer in a prospective randomized treatment protocol.
Silvestrini R; Daidone MG; Veneroni S; Benini E; Scarfone G; Zanaboni F; Villa A; Presti M; Danese S; Bolis G
Cancer; 1998 Jan; 82(1):159-67. PubMed ID: 9428493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]